Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Pratt

Showing results (311-320 of 325) with videos related to

Pageof 33
Sort By:
Blood Cancer Journal|December 10, 2016
Second malignancies in the context of lenalidomide treatment: an analysis of 2732 myeloma patients enrolled to the Myeloma XI trialJ R Jones, D A Cairns, W M Gregory, et al.
Leukemia|January 22, 2010
Variant IRF4/MUM1 associates with CD38 status and treatment-free survival in chronic lymphocytic leukaemiaJ M Allan, N J Sunter, J R Bailey, et al.
BMC Rheumatology|July 19, 2021
BIOlogical Factors that Limit sustAined Remission in rhEumatoid arthritis (the BIO-FLARE study): protocol for a non-randomised longitudinal cohort studyFiona Rayner, Amy E Anderson, Kenneth F Baker, et al.
Lancet (London, England)|February 16, 2024
Abatacept in individuals at high risk of rheumatoid arthritis (APIPPRA): a randomised, double-blind, multicentre, parallel, placebo-controlled, phase 2b clinical trialAndrew P Cope, Marianna Jasenecova, Joana C Vasconcelos, et al.
American Journal of Epidemiology|July 14, 2011
The PhenX Toolkit: get the most from your measuresCarol M Hamilton, Lisa C Strader, Joseph G Pratt, et al.
The Lancet. Rheumatology|January 23, 2026
Long-term outcomes of abatacept in individuals at risk of developing rheumatoid arthritis (ALTO): a randomised, double-blind, placebo-controlled trialAndrew P Cope, Marianna Jasenecova, Joana C Vasconcelos, et al.
Science Translational Medicine|July 26, 2023
Alterations in the gut microbiome implicate key taxa and metabolic pathways across inflammatory arthritis phenotypesKelsey N Thompson, Kevin S Bonham, Nicholas E Ilott, et al.
Trials|July 17, 2019
Arthritis prevention in the pre-clinical phase of RA with abatacept (the APIPPRA study): a multi-centre, randomised, double-blind, parallel-group, placebo-controlled clinical trial protocolMariam Al-Laith, Marianna Jasenecova, Sonya Abraham, et al.
Leukemia|November 4, 2014
Common variation at 12q24.13 (OAS3) influences chronic lymphocytic leukemia riskG P Sava, H E Speedy, M C Di Bernardo, et al.
RMD Open|February 11, 2026
Autoantibodies as predictors of progression to rheumatoid arthritis: a systematic review and meta-analysisSumera Qureshi, Maryam Adas, Phoebe J Cope, et al.
Pageof 33

Showing results (311-320 of 325) with videos related to

Sort By:
Pageof 33
Blood Cancer Journal|December 10, 2016
Second malignancies in the context of lenalidomide treatment: an analysis of 2732 myeloma patients enrolled to the Myeloma XI trialJ R Jones, D A Cairns, W M Gregory, et al.
Leukemia|January 22, 2010
Variant IRF4/MUM1 associates with CD38 status and treatment-free survival in chronic lymphocytic leukaemiaJ M Allan, N J Sunter, J R Bailey, et al.
BMC Rheumatology|July 19, 2021
BIOlogical Factors that Limit sustAined Remission in rhEumatoid arthritis (the BIO-FLARE study): protocol for a non-randomised longitudinal cohort studyFiona Rayner, Amy E Anderson, Kenneth F Baker, et al.
Lancet (London, England)|February 16, 2024
Abatacept in individuals at high risk of rheumatoid arthritis (APIPPRA): a randomised, double-blind, multicentre, parallel, placebo-controlled, phase 2b clinical trialAndrew P Cope, Marianna Jasenecova, Joana C Vasconcelos, et al.
American Journal of Epidemiology|July 14, 2011
The PhenX Toolkit: get the most from your measuresCarol M Hamilton, Lisa C Strader, Joseph G Pratt, et al.
The Lancet. Rheumatology|January 23, 2026
Long-term outcomes of abatacept in individuals at risk of developing rheumatoid arthritis (ALTO): a randomised, double-blind, placebo-controlled trialAndrew P Cope, Marianna Jasenecova, Joana C Vasconcelos, et al.
Science Translational Medicine|July 26, 2023
Alterations in the gut microbiome implicate key taxa and metabolic pathways across inflammatory arthritis phenotypesKelsey N Thompson, Kevin S Bonham, Nicholas E Ilott, et al.
Trials|July 17, 2019
Arthritis prevention in the pre-clinical phase of RA with abatacept (the APIPPRA study): a multi-centre, randomised, double-blind, parallel-group, placebo-controlled clinical trial protocolMariam Al-Laith, Marianna Jasenecova, Sonya Abraham, et al.
Leukemia|November 4, 2014
Common variation at 12q24.13 (OAS3) influences chronic lymphocytic leukemia riskG P Sava, H E Speedy, M C Di Bernardo, et al.
RMD Open|February 11, 2026
Autoantibodies as predictors of progression to rheumatoid arthritis: a systematic review and meta-analysisSumera Qureshi, Maryam Adas, Phoebe J Cope, et al.
Pageof 33